SCHEMBL6424749

SCHEMBL6424749

C=CC(=O)Nc1nncs1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
ALDH1A1 P00352 2/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 3/20 0.50
TAAR1 Q96RJ0 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
POLB P06746 4/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
MAPT P10636 1/20 0.46
GSTO1 P78417 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974323 0.79 NPC1 (0.58) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL19974322 0.79 NPC1 (0.58) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL3989080 0.79
SCHEMBL564354 0.76
SCHEMBL2116145 0.76 FFAR2 (0.47) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL9931373 0.75 MAPT (0.50) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL9932220 0.75 POLB (0.47) ALDH1A1HPGDHSD17B10SMN1; SMN2KDM4E
SCHEMBL10467309 0.75
SCHEMBL7876544 0.74 RAB9A (0.53) NPC1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL6380992 0.73 RAB9A (0.70) NPC1RAB9AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 WO disclosed